Chele Chiavacci Farley - 18 Dec 2024 Form 4 Insider Report for CONDUIT PHARMACEUTICALS INC. (CDT)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDT	Stock Option (Right to Buy)	Award	$29,820	+420,000		$0.0710	420,000	18 Dec 2024	Common Stock	420,000	$0.0710	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Represents options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan, which were granted at the conclusion of the Issuer's 2024 annual meeting of stockholders.
F2	The options will vest on the earlier of (x) the first anniversary of the date of grant, or (y) the date immediately prior to the next annual meeting of the Issuer's stockholders following the date of grant.